
Nectar Medipharma Private Limited
About Nectar Medipharma Private Limited
Data last updated:
Nectar Medipharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 October 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH1999PTC243788. Its GSTIN is 23AABCN2369P1Z5 (Madhya Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kruti Jigar Bathia and Shweta Nipun Sanghavi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 204A Janki Centre 2nd Floor Jeevan Nagar Off. Veera Desai Road Andheri West, Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.09 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹21.96 Lakh (net margin 3.6%) and EBITDA of ₹33.09 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Nectar Medipharma has one previous CIN (Corporate Identification Number): U24232RJ1999PTC015964. The current CIN is U24232MH1999PTC243788, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232MH1999PTC243788 | Current |
| U24232RJ1999PTC015964 | Previous |
Contact details
Nectar Medipharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressNo. 204A Janki Centre 2nd Floor Jeevan Nagar Off. Veera Desai Road Andheri West, Mumbai, Maharashtra, India – 400053
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nectar Medipharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nectar Medipharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Nectar Medipharma Private Limited, buy the company report.
Financials of Nectar Medipharma Private Limited
FY 2025 filings availableNectar Medipharma Private Limited reported revenue of ₹6.09 Cr (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.96 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nectar Medipharma Private Limited, buy the company report.
Board of directors of Nectar Medipharma Private Limited
Nectar Medipharma has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kruti Jigar Bathia Also directs: Premier Eyecare Private Limited | Director | 15 Jan 2015 | 11 Years 10 Months | Current |
| Shweta Nipun Sanghavi | Director | 15 Jan 2015 | 11 Years 10 Months | Current |
| Ashish Subhashbhai Desai Also directs: Bhavya Containers Private Limited | Director | 14 Jul 2011 | 15 Years 4 Months | Current |
| Jayendra Natverlal Desai Also directs: Bhavya Containers Private Limited | Director | 19 Nov 2020 | 6 Years 0 Months | Current |
| Gunjan Ashokbhai Desai Also directs: Bhavya Containers Private Limited | Director | 14 Oct 2014 | 12 Years 1 Months | Current |
Auditor
Nectar Medipharma Private Limited is audited by UMESH SHAH & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UMESH SHAH & ASSOCIATES | FY 2019 | 114563W |
Shareholding
The shareholding of Nectar Medipharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Nectar Medipharma Private Limited, buy the company report.
Legal cases
Nectar Medipharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (TMSUIT) | Filed against the company by Cadila Healthcare Ltd | Disposed |
To see the full case history of Nectar Medipharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nectar Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nectar Medipharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCN2369P1Z5 | Madhya Pradesh | Active | 01 Jul 2017 |
| 24AABCN2369P1Z3 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nectar Medipharma Private Limited, buy the company report.
Recent activity
Nectar Medipharma Private Limited has 10 board changes on record since 2011: 5 appointments and 5 cessations. The latest: Jayendra Natverlal Desai ceased to be Additional Director on 29 Nov 2021.
1 earlier event is in the company report.
Frequently asked questions
Nectar Medipharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 October 1999 (27+ years old) and is registered under CIN U24232MH1999PTC243788.
Nectar Medipharma has 5 current directors:
- Kruti Jigar Bathia - Director
- Shweta Nipun Sanghavi - Director
- Ashish Subhashbhai Desai - Director
- Jayendra Natverlal Desai - Director
- Gunjan Ashokbhai Desai - Director
The latest financial statements of Nectar Medipharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nectar Medipharma is 23AABCN2369P1Z5, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AABCN2369P1Z3 (Gujarat).
The CIN (Corporate Identification Number) of Nectar Medipharma is U24232MH1999PTC243788. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nectar Medipharma has 1 court case on record: 1 filed against it.
Nectar Medipharma was incorporated on 28 October 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.
Jayendra Natverlal Desai ceased to be Additional Director on 29 Nov 2021. Jayendra Natverlal Desai was appointed as Director on 19 Nov 2020. Gunjan Ashokbhai Desai ceased to be Additional Director on 30 Sep 2015. Nectar Medipharma has 10 board changes on record in total.
The registered office of Nectar Medipharma is at No. 204A Janki Centre 2nd Floor Jeevan Nagar Off. Veera Desai Road Andheri West, Mumbai, Maharashtra, India – 400053.
Nectar Medipharma operates in the pharma industry, in the drug formulation and development segment.

